Oscar Escobar
Pittsburgh, PANPI 1164495404
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,358 of the $2,144 with a category attached, or 63.3%. 7 manufacturers reported payments, led by Pfizer at 59.7% of the total. Reporting peaked in 2019 at $1,055 and has fallen 88.6% since, to $121 in 2025.
Across 14 payments — averaging $153.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1K
- Novo Nordisk$362
- Biomarin Pharmaceutical Inc.$202
- Tolmar, Inc.$176
- Ultragenyx Pharmaceutical Inc.$86
- Chiesi USA, Inc.$21
- plus $17 from 1 others
Across 559 payments — averaging $638.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$141K
- Novo Nordisk AS$121K
- OPKO Pharmaceuticals, LLC$85K
- Novo Nordisk$10K
What the payments were for
- Travel & lodging$74735%
- Food & beverage$1,35863%
- Education$392%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 5 | $1,280 |
| Novo Nordisk | 3 | $362 |
| Biomarin Pharmaceutical Inc. | 2 | $202 |
| Tolmar, Inc. | 1 | $176 |
| Ultragenyx Pharmaceutical Inc. | 1 | $86 |
| Chiesi USA, Inc. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENOTROPIN$690
- Sogroya$242
- NGENLA$186
- FENSOLVI$176
- VOXZOGO 1.2mg$131
- Norditropin$120
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.